NRIP3 upregulation, tumor invasion, lymph node metastasis and TNM staging were significantly associated with overall survival (P < 0.001), while there was no significant correlation between sex, age, and tumor differentiation and overall survival time. This evidence concerns the gene NRIP3 and metastatic malignant neoplasm in the lymph nodes.